DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

GlaxoSmithKline Earlier Reported Q4 EPS $0.33 May Not Compare To $0.73 Estimate, Sales $11.836B Miss $12.14B Estimate

GlaxoSmithKline (NYSE:GSK) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.73 by 54.79 percent. This is a 17.5 percent decrease over earnings of $0.4 per share from the

Benzinga · 02/05/2020 14:16

GlaxoSmithKline (NYSE:GSK) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.73 by 54.79 percent. This is a 17.5 percent decrease over earnings of $0.4 per share from the same period last year. The company reported quarterly sales of $11.836 billion which missed the analyst consensus estimate of $12.14 billion by 2.50 percent. This is a 13.70 percent increase over sales of $10.41 billion the same period last year.